Cleared Traditional

K203359 - BD Flu+ Syringe

K203359 is an FDA 510(k) clearance for BD Flu+ Syringe, manufactured by Becton, Dickinson and Company. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 254-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2021
Decision
254d
Days
Class 2
Risk

K203359 is an FDA 510(k) clearance for the BD Flu+ Syringe. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Becton, Dickinson and Company (Franklin Lakes, US). The FDA issued a Cleared decision on July 28, 2021 after a review of 254 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Becton, Dickinson and Company devices

FDA 510(k) Submission Details - K203359

510(k) Number K203359 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 2020
Decision Date July 28, 2021
Days to Decision 254 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
125d slower than avg
Panel avg: 129d · This submission: 254d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 480
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K203359.
PreferX Delivery System
K210997 · Md3, LLC · Sep 2021
Disposable Sterile Syringe, Disposable Sterile Syringe with Needle
K210991 · Guangdong Antmed Co., Ltd. · Aug 2021
Auto Disable Syringe
K210464 · Anhui Tiankang Medical Technology Co., Ltd. · Aug 2021
SAFEWAY, LIFELONG PREMIUM, LIFELONG MATRIX
K210103 · Lifelong Meditech Private Limited · Jul 2021
1 ml Sterile Hypodermic Syringe For Single Use. With/Without Needle. Luer/Luer-Lock
K210200 · Set Medikal Sanayi VE Ticaret Anonim Sirketi · May 2021
MicroDose Injector
K203264 · Medone Surgical, Inc. · Apr 2021